ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,138 | -39.8% | 4,547 | -9.9% | 0.02% | -35.3% |
| Q2 2023 | $899,503 | +5.6% | 5,048 | -2.2% | 0.03% | 0.0% |
| Q1 2023 | $851,688 | -11.5% | 5,163 | 0.0% | 0.03% | -12.8% |
| Q4 2022 | $962,435 | +23.9% | 5,163 | 0.0% | 0.04% | +11.4% |
| Q3 2022 | $777,000 | -10.5% | 5,163 | -2.2% | 0.04% | -5.4% |
| Q2 2022 | $868,000 | -26.2% | 5,281 | 0.0% | 0.04% | -11.9% |
| Q1 2022 | $1,176,000 | -6.1% | 5,281 | 0.0% | 0.04% | 0.0% |
| Q4 2021 | $1,253,000 | +1.7% | 5,281 | 0.0% | 0.04% | -6.7% |
| Q3 2021 | $1,232,000 | +11.0% | 5,281 | -2.1% | 0.04% | +12.5% |
| Q2 2021 | $1,110,000 | +0.2% | 5,393 | 0.0% | 0.04% | -4.8% |
| Q1 2021 | $1,108,000 | -4.2% | 5,393 | 0.0% | 0.04% | -20.8% |
| Q4 2020 | $1,157,000 | +14.8% | 5,393 | -2.2% | 0.05% | +15.2% |
| Q3 2020 | $1,008,000 | -2.4% | 5,513 | -1.6% | 0.05% | -6.1% |
| Q2 2020 | $1,033,000 | -5.7% | 5,605 | +3.1% | 0.05% | -21.0% |
| Q1 2020 | $1,096,000 | +7.8% | 5,434 | 0.0% | 0.06% | +37.8% |
| Q4 2019 | $1,017,000 | +17.3% | 5,434 | 0.0% | 0.04% | +12.5% |
| Q3 2019 | $867,000 | -29.7% | 5,434 | +10.9% | 0.04% | -28.6% |
| Q2 2019 | $1,234,000 | +5.3% | 4,899 | 0.0% | 0.06% | +1.8% |
| Q1 2019 | $1,172,000 | +4.2% | 4,899 | 0.0% | 0.06% | -9.8% |
| Q4 2018 | $1,125,000 | -18.8% | 4,899 | 0.0% | 0.06% | -4.7% |
| Q3 2018 | $1,385,000 | +5.0% | 4,899 | +9.0% | 0.06% | +1.6% |
| Q2 2018 | $1,319,000 | -9.5% | 4,493 | -22.2% | 0.06% | -10.0% |
| Q1 2018 | $1,458,000 | +411.6% | 5,778 | +337.4% | 0.07% | +438.5% |
| Q4 2017 | $285,000 | +23.9% | 1,321 | 0.0% | 0.01% | +18.2% |
| Q3 2017 | $230,000 | +0.9% | 1,321 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $228,000 | +17.5% | 1,321 | +4.0% | 0.01% | +10.0% |
| Q1 2017 | $194,000 | – | 1,270 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |